Abishek Saravanan: Neuroprotective Benefits of Sovateltide in Real-World Stroke Management
Abishek Saravanan, Pharmacist Executive at Parekh Integrated Services Pvt. Ltd., shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Publication Announcement | Research Milestone Achieved
I am delighted to share that our research article titled:
Real-world functional outcomes of sovateltide as an adjunct to standard therapy in acute ischemic stroke: A prospective observational study’ has been successfully published in Medicine (journal) (Vol. 105, Issue 8, 2026).
This study evaluates the real-world effectiveness of sovateltide as an adjunct therapy in patients with acute ischemic stroke, focusing on functional recovery and neurological outcomes when combined with standard stroke management.
Key Highlights:
- Prospective observational evaluation in patients with acute ischemic stroke
- Assessment of functional recovery outcomes with adjunct sovateltide therapy
- Real-world clinical evidence supporting neuroprotective strategies in stroke management
- Contribution to the growing research on novel therapeutic approaches for improving stroke recovery
I sincerely thank all my co-authors, mentors, and collaborators for their valuable guidance and support throughout this research work.
This publication represents another step forward in advancing clinical research in neurology and pharmacy practice.”
Title: Real-world functional outcomes of sovateltide as an adjunct to standard therapy in acute ischemic stroke: A prospective observational study
Authors: Geetha Kandasamy, Lavanya Selvaraj, Khalid Orayj, Mona Almanasef, Amjad Hmlan, Rayah Asiri, Afaf Ahmed Aldahish, Vasudevan Mani, Abishek M Saravanan, Kousalya Prabahar
Read the Full Article on Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation